Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clarithromycin as Adjuvant to Periodontal Debridement in the Treatment of Generalized Aggressive Periodontitis: Randomized Clinical Trial
Brief Summary: To assess the periodontal clinical response and the possible adverse effects of the clarithromycin combined to periodontal mechanical therapy in the treatment of patients with generalized aggressive periodontitis.


Options:
A: Arm Label: clarithromycin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clarithromycin, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Arm Label: placebo group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Other: One-stage full-mouth ultrasonic debridement (FMUD) | Intervention Type: DRUG; Name: Clarithromycin; Assigned to Arm(s): clarithromycin group | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo group | Intervention Type: OTHER; Name: One-stage full-mouth ultrasonic debridement (FMUD); Assigned to Arm(s): clarithromycin group, placebo group
B: Arm Label: YH14642 A-I; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-II; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: YH14642 A-III; Type: EXPERIMENTAL; Interventions: Drug: YH14642 500mg Tab | Arm Label: Active Comparator B; Type: ACTIVE_COMPARATOR; Interventions: Drug: INSADOL[Zea mays L. extract] 35mg Tab | Arm Label: Active Comparator C; Type: ACTIVE_COMPARATOR; Interventions: Drug: DENTISTA[Doxycycline hyclate] 20mg Cap | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-I | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-II | Intervention Type: DRUG; Name: YH14642 500mg Tab; Assigned to Arm(s): YH14642 A-III | Intervention Type: DRUG; Name: INSADOL[Zea mays L. extract] 35mg Tab; Assigned to Arm(s): Active Comparator B | Intervention Type: DRUG; Name: DENTISTA[Doxycycline hyclate] 20mg Cap; Assigned to Arm(s): Active Comparator C | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: scaling and root planing; Type: PLACEBO_COMPARATOR; Interventions: Other: scaling and root planing | Arm Label: scaling and systemic moxifloxacin; Type: EXPERIMENTAL; Interventions: Other: scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and systemic moxifloxacin; Assigned to Arm(s): scaling and systemic moxifloxacin | Intervention Type: OTHER; Name: scaling and root planing; Assigned to Arm(s): scaling and root planing
D: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Scaling and root planing (SRP), Other: Placebo 400 (14 days), Other: Placebo 500 | Arm Label: MTZ 250 (7 days); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing (SRP), Drug: Metronidazole 250 (7 days), Drug: Amoxicillin, Other: Placebo 250 (7 days) | Arm Label: MTZ 400 (7 days); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing (SRP), Drug: Metronidazole 400 (7 days), Drug: Amoxicillin, Other: Placebo 400 (7 days) | Arm Label: MTZ 250 (14 days); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing (SRP), Drug: Metronidazole 250 (14 days), Drug: Amoxicillin | Arm Label: MTZ 400 (14 days); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Scaling and root planing (SRP), Drug: Metronidazole 400 (14 days), Drug: Amoxicillin | Intervention Type: PROCEDURE; Name: Scaling and root planing (SRP); Assigned to Arm(s): Control, MTZ 250 (14 days), MTZ 250 (7 days), MTZ 400 (14 days), MTZ 400 (7 days) | Intervention Type: DRUG; Name: Metronidazole 250 (7 days); Assigned to Arm(s): MTZ 250 (7 days) | Intervention Type: DRUG; Name: Metronidazole 400 (7 days); Assigned to Arm(s): MTZ 400 (7 days) | Intervention Type: DRUG; Name: Metronidazole 250 (14 days); Assigned to Arm(s): MTZ 250 (14 days) | Intervention Type: DRUG; Name: Metronidazole 400 (14 days); Assigned to Arm(s): MTZ 400 (14 days) | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): MTZ 250 (14 days), MTZ 250 (7 days), MTZ 400 (14 days), MTZ 400 (7 days) | Intervention Type: OTHER; Name: Placebo 250 (7 days); Assigned to Arm(s): MTZ 250 (7 days) | Intervention Type: OTHER; Name: Placebo 400 (7 days); Assigned to Arm(s): MTZ 400 (7 days) | Intervention Type: OTHER; Name: Placebo 400 (14 days); Assigned to Arm(s): Control | Intervention Type: OTHER; Name: Placebo 500; Assigned to Arm(s): Control

Answer: A